NASDAQ: AFYA
Afya Ltd Stock

$15.27+0.27 (+1.8%)
Updated Jul 2, 2026
AFYA Price
$15.27
Fair Value Price
$30.56
Market Cap
$1.43B
52 Week Low
$13.00
52 Week High
$17.48
P/E
9x
P/B
1.5x
P/S
1.93x
PEG
0.07x
Dividend Yield
1.52%
Revenue
$760.81M
Earnings
$144.83M
Gross Margin
64.3%
Operating Margin
38.1%
Profit Margin
20.1%
Debt to Equity
1.02
Operating Cash Flow
$293M
Beta
0.83
Next Earnings
Aug 12, 2026
Ex-Dividend
N/A
Next Dividend
N/A

AFYA Overview

Afya Limited, operating through its subsidiaries, is a prominent medical education provider in Brazil. The company delivers a comprehensive array of educational products and services primarily focused on the medical field, encompassing medical schools, preparatory courses for medical residency, advanced graduate studies, and various other programs tailored for medical professionals at all career stages. These offerings are available across its proprietary network and are also extended to external medical institutions. Beyond traditional education, Afya also offers digital health services through a subscription-based platform, accessible via a mobile app and website. This platform is specifically designed to assist healthcare practitioners and students with clinical decision-making by providing essential tools such as medical calculators, reference charts, up-to-date content, prescription guidance, clinical scoring systems, details on medical procedures, and laboratory examination information. While strong in medicine, Afya's educational portfolio spans a broader spectrum of health sciences, including dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine. Furthermore, the company extends its academic offerings beyond healthcare to include undergraduate and postgraduate degree programs in diverse subjects like business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. The company further enhances its educational ecosystem by providing specialized postgraduate medical programs, both printed and digital educational materials, an online medical learning platform, and hands-on medical training opportunities. As of December 31, 2021, Afya maintained an extensive network of 46 undergraduate and graduate medical school campuses, which included 30 operational undergraduate units and five approved units. This infrastructure supported a total capacity of 2,731 medical school seats, with 2,481 actively operating and an additional 278 seats approved for future use. Established in 1999, Afya Limited is headquartered in Nova Lima, Brazil.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine AFYA's potential to beat the market

BBuy
  • Stocks with a Zen Rating of Buy (B) had an average return of +17.17% per year. Learn More

Zen Rating Component Grades

A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Education

Industry Rating
B
AFYA
Ranked
#4 of 27

Top Ranked Stocks in Industry

View Top Education Stocks

Be the first to know about important AFYA news, forecast changes, insider trades & much more!

AFYA News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AFYA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AFYA ($15.27) is undervalued by 50.03% relative to our estimate of its Fair Value price of $30.56 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AFYA ($15.27) is significantly undervalued by 50.03% relative to our estimate of its Fair Value price of $30.56 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
AFYA ($15.27) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more AFYA due diligence checks available for Premium users.

Valuation

AFYA fair value

Fair Value of AFYA stock based on Discounted Cash Flow (DCF)

Price
$15.27
Fair Value
$30.56
Undervalued by
50.03%
AFYA ($15.27) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AFYA ($15.27) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AFYA ($15.27) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AFYA price to earnings (PE)

For valuing profitable companies with steady earnings

Company
9x
Industry
19.77x
Market
8.54x
AFYA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
AFYA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

AFYA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
1.5x
Industry
2.19x
AFYA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AFYA price to earnings growth (PEG)

For valuing profitable companies with growth potential

AFYA is good value based... subscribe to Premium to read more.
PEG Value Valuation

AFYA's financial health

Profit margin

Revenue
$193.6M
Net Income
$49.1M
Profit Margin
25.4%
AFYA's Earnings (EBIT) of $289.89M... subscribe to Premium to read more.
Interest Coverage Financials
AFYA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.8B
Liabilities
$925.2M
Debt to equity
1.02
AFYA's short-term assets ($448.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AFYA's long-term liabilities ($724.19M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AFYA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AFYA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$89.3M
Investing
-$21.0M
Financing
-$28.4M
AFYA's operating cash flow ($309.38M)... subscribe to Premium to read more.
Debt Coverage Financials

AFYA vs Education Stocks

TickerZen RatingMarket Cap1d %P/EP/B
AFYAB$1.43B+1.80%9.00x1.50x
DAOC$1.52B+4.92%N/A-5.33x
PXEDB$1.23B+0.17%N/A4.23x
LINCC$1.66B-0.53%72.68x8.35x
APEIB$1.04B+1.54%29.09x3.40x

Afya Stock FAQ

What is Afya's quote symbol?

(NASDAQ: AFYA) Afya trades on the NASDAQ under the ticker symbol AFYA. Afya stock quotes can also be displayed as NASDAQ: AFYA.

If you're new to stock investing, here's how to buy Afya stock.

What is the 52 week high and low for Afya (NASDAQ: AFYA)?

(NASDAQ: AFYA) Afya's 52-week high was $17.48, and its 52-week low was $13.00. It is currently -12.63% from its 52-week high and 17.46% from its 52-week low.

How much is Afya stock worth today?

(NASDAQ: AFYA) Afya currently has 93,722,831 outstanding shares. With Afya stock trading at $15.27 per share, the total value of Afya stock (market capitalization) is $1.43B.

Afya stock was originally listed at a price of $24.09 in Jul 19, 2019. If you had invested in Afya stock at $24.09, your return over the last 6 years would have been -36.61%, for an annualized return of -7.32% (not including any dividends or dividend reinvestments).

How much is Afya's stock price per share?

(NASDAQ: AFYA) Afya stock price per share is $15.27 today (as of Jul 2, 2026).

What is Afya's Market Cap?

(NASDAQ: AFYA) Afya's market cap is $1.43B, as of Jul 7, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Afya's market cap is calculated by multiplying AFYA's current stock price of $15.27 by AFYA's total outstanding shares of 93,722,831.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.